search
Company Information
USD
0.82
- (1.2%)
NASDAQ:HOOK, HOOKIPA PHARMA INC.
Industry: Biotechnology
End of Day: 17 May 2024 GMT-4
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Address

350 Fifth Avenue
72nd Floor, Suite 7240

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Ms. Mary Theresa Coelho
Director
Mr. Roman Necina
COO
Mr. Joern Aldag
CEO/Director
Mr. Reinhard Kandera
CFO/Chief Accounting Officer/Director
Dr. Jan G. J. van de Winkel, PhD
Chairman of the Board/Director
Ms. Julie O'Neill
Director
Mr. Klaus Orlinger
Chief Scientific Officer
Mr. David Ross Kaufman
Director
Dr. Malte Peters, M.D.
Director
Dr. Timothy P. Reilly
Director
Ms. Katia Schlienger
Chief Medical Officer

Ownership

Institution Holdings

Gilead Sciences Inc
18,759,465 (18.959%)
Baker Bros Advisors LP
8,128,151 (8.214%)
Artal Group S A
5,666,410 (5.727%)
Knoll Capital Management LP
5,517,385 (5.576%)
EcoR1 Capital, LLC
4,595,024 (4.644%)
Fidelity Management & Research Company LLC
3,747,230 (3.787%)
Baker Bros. Advisors LP
3,475,535 (3.512%)
FMR LLC
3,358,547 (3.394%)
FMR Inc
3,358,383 (3.394%)
Alyeska Investment Group, L.P.
3,109,436 (3.142%)

Individual Holdings

Mr. Joern Aldag
71,952 (0.088%)
Mr. Roman Necina
14,876 (0.054%)
Mr. Reinhard Kandera
43,092 (0.053%)
Dr. Jan G. J. van de Winkel, PhD
9,153 (0.042%)
Mr. Klaus Orlinger
10,404 (0.038%)
Ms. Julie O'Neill
4,969 (0.023%)
Mr. David Ross Kaufman
4,577 (0.021%)

Funds Holdings

Fidelity Extended Market Index Fund
363,737 (0.368%)
iShares Micro-Cap ETF
167,706 (0.169%)
BlackRock Extended Equity Market
54,989 (0.056%)
NT Ext Equity Mkt Idx Fd - DC - NL
32,244 (0.033%)
Extended Equity Market Fund M
6,799 (0.007%)
SSgA U.S. Total Market Index Fund
2,711 (0.003%)
BNYM Mellon SL Market Completion Fund
1,311 (0.001%)
NT Ext Equity Mkt Indx Fd DC Lending
1,298 (0.001%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices